Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer

TRA-8, a monoclonal antibody targeting death receptor, has demonstrated high therapeutic effect for triple negative breast cancer (TNBC) in preclinical models. Tamoxifen, the standard of care for ERα-positive breast cancer, induces apoptosis via ERβ, which commonly presents in TNBC cells. The curren...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kim, Hyunki, Samuel, Sharon L, Zhai, Guihua, Rana, Samir, Taylor, Marie, Umphrey, Heidi R, Oelschlager, Denise K, Buchsbaum, Donald J, Zinn, Kurt R
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2014
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119072/
https://ncbi.nlm.nih.gov/pubmed/25084100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.29183
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items